Thoracic Paravertebral Block : Effect on Acute Pain and Chronic Pain of Hepatectomy With Right J-shape Subcostal Incision
NCT ID: NCT02817321
Last Updated: 2019-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
76 participants
INTERVENTIONAL
2016-11-30
2018-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision
NCT02914015
Continuous Paravertebral Block on Postoperative Quality of Recovery After Hepatectomy
NCT03777644
The Analgesic Efficacy of Ultrasound Guided Transversus Abdominal Plane Block After Abdominal Cancer Surgeries
NCT03165383
Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural Analgesia in Patients Undergoing Major Abdominal Cancer Surgery
NCT07273136
External Oblique Intercostal Plane Block for Postoperative Analgesia After Major Upper Abdominal Surgery
NCT07331441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single-injection TPVB +continuous TPVB
Single-injection of TPVB is given preoperatively followed with continuous infusion+ postoperative IPCA.
single-injection TPVB + continuous TPVB
Inject local anesthetics in the T8 paravertebral space followed with catheter insertion and continuous local infusion.
Philip CX50 Ultrasound Scanner
The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scanning
PAJUNK Contiplex S Catheter
single dose ropivacaine
* 2mg/kg ropivacaine in saline with 1:200,000 adrenaline, 25ml in total
* given immediately after the correct position of the tip of the needle has been confirmed
continuously infusion of ropivacaine
* 0.2% ropivacaine, pulse dosadge: 0.125ml/kg/pulse, 1pulse/h at a rate of 6ml/minutes
* given through the catheter inserted in the T8 paravertebral space following the single dose
Morphine given as IPCA
bolus: 2mg, lock time: 10min, 1h limitation: 8mg
IPCA
postoperative IPCA is given alone
Morphine given as IPCA
bolus: 2mg, lock time: 10min, 1h limitation: 8mg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
single-injection TPVB + continuous TPVB
Inject local anesthetics in the T8 paravertebral space followed with catheter insertion and continuous local infusion.
Philip CX50 Ultrasound Scanner
The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scanning
PAJUNK Contiplex S Catheter
single dose ropivacaine
* 2mg/kg ropivacaine in saline with 1:200,000 adrenaline, 25ml in total
* given immediately after the correct position of the tip of the needle has been confirmed
continuously infusion of ropivacaine
* 0.2% ropivacaine, pulse dosadge: 0.125ml/kg/pulse, 1pulse/h at a rate of 6ml/minutes
* given through the catheter inserted in the T8 paravertebral space following the single dose
Morphine given as IPCA
bolus: 2mg, lock time: 10min, 1h limitation: 8mg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists physical statusⅠ-Ⅲ
* Undergo hepatectomy with J-shape subcostal incision
* Informed consent
Exclusion Criteria
* Coagulopathy, on anticoagulants
* Analgesics intake, history of substance abuse
* Participating in the investigation of another experimental agent
* Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cui Xulei
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cui Xulei
Attending physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yuguang Huang, MD.
Role: STUDY_CHAIR
Peking Union Medical College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xulei CUI
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cuixulei2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.